MFN update with Tim Wright, Genesis Research Group.
How fit-for-purpose data turns evidence complexity into decision-ready insights.
Navigate the literature review spectrum and gain practical insight into selecting the most appropriate review approach for your evidence needs.
Melissa Moore-Clingenpeel (Thermo Fisher Scientific) explores how independent prospective registries complement secondary-use RWE.
A discussion with the ROI of HEOR Working Group representatives.
Deep Dive from the World Orphan Drug Congress USA 2026.
